This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| BS-TBS | |
|---|---|
| Name | BS-TBS |
BS-TBS
BS-TBS is an industrially relevant compound employed across pharmaceutical industry, semiconductor industry, aerospace industry, automotive industry and biotechnology industry supply chains. It functions as a multifunctional reagent and processing aid in contexts ranging from organic synthesis to surface treatment and microfabrication, and is referenced in standards and technical manuals produced by organizations such as International Organization for Standardization, American Society for Testing and Materials, and International Electrotechnical Commission.
BS-TBS is characterized by a hybrid molecular architecture that combines sterically hindered silyl protection motifs similar to those used with tert-butyldimethylsilyl chloride and boron-centered functionality encountered in boronic acid derivatives. In industrial formulations it is handled alongside reagents common to Merck Group, BASF, Dow Chemical Company, DuPont, and Evonik Industries supply lines. Use-cases situate it near technologies developed at research centers including Massachusetts Institute of Technology, California Institute of Technology, ETH Zurich, University of Cambridge, and Imperial College London.
Development traces to late-20th-century advances in organosilicon and organoboron chemistry pioneered by researchers associated with Nobel Prize in Chemistry work on cross-coupling reactions and protecting group chemistry. Early adoption paralleled innovations at Bell Labs, Rutherford Appleton Laboratory, Lawrence Berkeley National Laboratory, and industrial research groups at IBM Research, Hitachi Global, Siemens, and Toyota Central R&D Labs. Patents filed with authorities such as the United States Patent and Trademark Office, European Patent Office, and Japan Patent Office chart commercialization alongside processes used at plants operated by ExxonMobil and Shell plc. Conferences like American Chemical Society national meeting, Gordon Research Conferences, IUPAC World Chemistry Congress, and symposia at RSC venues disseminated methodological refinements.
BS-TBS exhibits reactivity patterns resembling silyl ethers and boronate esters studied in Heck reaction, Suzuki–Miyaura reaction, Stille reaction, and Negishi coupling contexts. Spectroscopic signatures are comparable to compounds analyzed using Nuclear Magnetic Resonance, Infrared spectroscopy, Mass spectrometry, and X-ray crystallography instruments from vendors like Bruker Corporation and Thermo Fisher Scientific. Thermal properties are evaluated using Differential Scanning Calorimetry and Thermogravimetric Analysis equipment, and decomposition pathways reference mechanisms reported in literature by groups at Scripps Research, Max Planck Institute for Coal Research, Riken, and Tohoku University. Compatibility tables align with solvents supplied by Sigma-Aldrich, Fisher Scientific, and VWR International.
BS-TBS is applied in synthetic sequences relevant to active pharmaceutical ingredient routes for molecules linked to Pfizer, Roche, Novartis, Johnson & Johnson, and GlaxoSmithKline. It appears in protocols for microfabrication alongside etchants and resists used by TSMC, Intel Corporation, Samsung Electronics, GlobalFoundries, and research fabs at IMEC. In materials science it features in surface functionalization and adhesion promotion studied at Lawrence Livermore National Laboratory and Oak Ridge National Laboratory, and in catalyst supports investigated by teams at Caltech and Stanford University. Additional uses include intermediacy in syntheses reported in journals from American Chemical Society, Nature Publishing Group, Elsevier, and Wiley-Blackwell.
Risk assessments for BS-TBS follow frameworks similar to those promulgated by Occupational Safety and Health Administration, European Chemicals Agency, National Institute for Occupational Safety and Health, and World Health Organization. Toxicological endpoints are evaluated with assays comparable to those used by U.S. Environmental Protection Agency and European Food Safety Authority, and incident responses align with guidance from International Maritime Organization and National Fire Protection Association. Environmental fate models use approaches like those in reports by United Nations Environment Programme, Intergovernmental Panel on Climate Change, and studies from CSIRO and Natural Resources Canada for persistence, bioaccumulation, and aquatic toxicity profiling.
Regulatory handling follows classifications and transport rules coordinated by Globally Harmonized System of Classification and Labelling of Chemicals, International Air Transport Association, International Maritime Organization, Occupational Safety and Health Administration Hazard Communication Standard, and regional regulators such as European Chemicals Agency. Standards for analytical testing and quality control reference methods from ISO, ASTM International, British Standards Institution, and pharmacopeias including the United States Pharmacopeia and European Pharmacopoeia. Industry compliance often involves audits by firms like Bureau Veritas, SGS, and Intertek Group.
Ongoing R&D explores improved synthetic routes, catalyst systems, and greener processing aligned with initiatives at Horizon 2020, National Science Foundation, Japan Science and Technology Agency, and German Research Foundation. Collaborative projects involve universities and national labs such as Yale University, Princeton University, Karolinska Institute, KU Leuven, and Seoul National University. Research directions include alternatives inspired by green chemistry principles, scale-up studies with partners like Honeywell UOP and Linde plc, and computational chemistry modeling using platforms developed at Lawrence Livermore National Laboratory and Argonne National Laboratory.
Category:Organosilicon compounds